The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study

被引:0
作者
Joyce H. Park
Amanda Bienenfeld
Seth J. Orlow
Arielle R. Nagler
机构
[1] New York University Langone Health,The Ronald O. Perelman Department of Dermatology
[2] New York University School of Medicine,undefined
来源
American Journal of Clinical Dermatology | 2018年 / 19卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:449 / 455
页数:6
相关论文
共 133 条
  • [11] Barros B(2016)Guidelines of care for the management of acne vulgaris J Am Acad Dermatol. 74 945e33-973e33
  • [12] Thiboutot D(2012)Combined oral contraceptives for the treatment of acne: a practical guide Cutis 90 83-90
  • [13] Deplewski D(2015)Is hormonal treatment still an option in acne today? Br J Dermatol 172 37-46
  • [14] Rosenfield RL(1979)Interaction of spironolactone with rat skin androgen receptor Can J Biochem 57 1042-1046
  • [15] Das S(2009)Should dermatologists prescribe hormonal contraceptives for acne? Dermatol Ther. 22 452-457
  • [16] Reynolds RV(2010)Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne Int J Womens Health. 1 213-221
  • [17] Dreno B(2014)Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris J Am Acad Dermatol 71 450-459
  • [18] Layton A(1984)Oral spironolactone improves acne vulgaris and reduces sebum excretion Br J Dermatol 111 209-214
  • [19] Zouboulis CC(1986)Oral spironolactone: an effective treatment for acne vulgaris in women Br J Dermatol 115 227-232
  • [20] Lopez-Estebaranz JL(2009)Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne Cochrane Database Syst Rev. 15 CD000194-191